To evaluate the clinical relevance of the NUDT5-mediated thiopurine response, we comprehensively characterized genetic variations of NUDT5 in 582 children with ALL enrolled on the Children’s Oncology Group AALL03N1 trial, for whom systematic data on MP-related myelosuppression were collected (13). Here, NUDT5 is linked to acute lymphoblastic leukemia.